文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Continuous immunosuppression is required for suppressing immune responses to xenografts in non-human primate brains.

作者信息

Feng Su, Zhang Ting, He Zhengxiao, Zhang Wenchang, Chen Yingying, Yue Chunmei, Jing Naihe

机构信息

Guangzhou National Laboratory, Guangzhou, 510005, China.

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.

出版信息

Cell Regen. 2024 Apr 7;13(1):8. doi: 10.1186/s13619-024-00191-0.


DOI:10.1186/s13619-024-00191-0
PMID:38583099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10999398/
Abstract

Continuous immunosuppression has been widely used in xenografts into non-human primate brains. However, how immune responses change after transplantation in host brains under continuous immunosuppressive administration and whether immunosuppression can be withdrawn to mitigate side effects remain unclear. Human induced neural stem/progenitor cells (iNPCs) have shown long-term survival and efficient neuronal differentiation in primate brains. Here, we evaluate the immune responses in primate brains triggered by human grafts. The results show that the immune responses, including the evident activation of microglia and the strong infiltration of lymphocytes (both T- and B-cells), are caused by xenografts at 4 months post transplantation (p.t.), but significantly reduced at 8 months p.t. under continuous administration of immunosuppressant Cyclosporin A. However, early immunosuppressant withdrawal at 5 months p.t. results in severe immune responses at 10 months p.t. These results suggest that continuous long-term immunosuppression is required for suppressing immune responses to xenografts in primate brains.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/d5323b9d0d11/13619_2024_191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/e110ebe59451/13619_2024_191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/2b87873a5e67/13619_2024_191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/d5323b9d0d11/13619_2024_191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/e110ebe59451/13619_2024_191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/2b87873a5e67/13619_2024_191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c05/10999398/d5323b9d0d11/13619_2024_191_Fig3_HTML.jpg

相似文献

[1]
Continuous immunosuppression is required for suppressing immune responses to xenografts in non-human primate brains.

Cell Regen. 2024-4-7

[2]
Hypoproliferative human neural progenitor cell xenografts survived extendedly in the brain of immunocompetent rats.

Stem Cell Res Ther. 2021-7-2

[3]
Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts.

Xenotransplantation. 2003-7

[4]
Therapeutic regulation of systemic inflammation in xenograft recipients.

Xenotransplantation. 2017-3

[5]
Cell Therapy for Parkinson's Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression.

Am J Transplant. 2016-7

[6]
Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord.

J Clin Neurosci. 2018-2

[7]
Survival of transplanted human neural stem cell line (ReNcell VM) into the rat brain with and without immunosuppression.

Ann Anat. 2012-5-22

[8]
Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats.

Exp Neurol. 2001-1

[9]
Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection.

Exp Neurol. 2001-11

[10]
Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain.

Clin Transl Med. 2022-9

引用本文的文献

[1]
Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies.

Brain Res Bull. 2025-5

本文引用的文献

[1]
Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.

Exp Neurol. 2024-4

[2]
Co-transplantation of autologous T cells in a cell therapy for Parkinson's disease.

Nature. 2023-7

[3]
Cell therapy in ALS: An update on preclinical and clinical studies.

Brain Res Bull. 2023-3

[4]
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.

J Mov Disord. 2023-1

[5]
The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease.

Cell Regen. 2022-9-2

[6]
Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects.

Front Cell Dev Biol. 2022-3-16

[7]
Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer's disease in nonhuman primates.

iScience. 2021-9-30

[8]
Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.

Mov Disord. 2021-8

[9]
Traumatic brain injury does not disrupt costimulatory blockade-induced immunological tolerance to glial-restricted progenitor allografts.

J Neuroinflammation. 2021-4-30

[10]
Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.

J Clin Invest. 2021-6-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索